In Spain the survival of patients with prostate cancer has increased significantly from 1999 to 2003, probably due to the advancement in diagnosis produced by the opportunistic screening of prostate-specific antigen (PSA). Differences in the dissemination and use of the PSA level could explain the observed geographic differences in the increase of survival. It would be necessary to carry out studies to quantify the produced overdiagnosis by screening with PSA in prostate cancer.
The RP has a positive effect on patients with mild- to moderate-phase AD. However, we identified no effect for the RP on cognitive ability. These findings provide empirical evidence to support the use of RP as an effective complementary therapy. Improving the physical capacity and the QOL may have important long-term benefits for the older adults and their caregivers. The results of this study should be helpful to decision makers and geriatric health centers in planning and implementing RPs for elderly people with AD.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.